Skip to content
Tech News
← Back to articles

CRISPR gene-editing therapy sustains 50% cholesterol drop for a full year, Cleveland Clinic finds

read original get Omron Platinum Blood Pressure Monitor (BP5450) → more articles
GoKawiil Brief

An updated study published in the New England Journal of Medicine shows that a one-time CRISPR-Cas9 gene-editing infusion kept LDL cholesterol and triglycerides roughly 50% lower a full year after treatment in patients who received the highest dose. The follow-up builds on a small November 2025 pilot trial of 15 patients with medication-resistant high cholesterol, testing five dosage levels for safety, with researchers now confirming the effect appears durable rather than temporary.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

High cholesterol that resists standard drugs remains a major driver of heart disease, and a durable one-time gene edit could eliminate the need for lifelong daily medication, especially for younger patients facing decades of treatment. While the sample size is still tiny, the persistence of results a year out strengthens the case for larger trials that could validate CRISPR-based cholesterol therapy as a practical alternative to pills or injections.

Key Takeaways
Worth a Look

Omron Platinum Blood Pressure Monitor (BP5450) — While CRISPR cholesterol therapy is still experimental, tracking your own cardiovascular numbers at home is something you can do today. The Omron Platinum upper-arm monitor stores readings and syncs with the Omron Connect app, making it easy to share trends with your doctor alongside your lipid panel.

See Omron Platinum Blood Pressure Monitor (BP5450) on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.

Source: science.slashdot.org — Posted, 2026-08-29

Published there as: “With the Snip of a Gene, Scientists Hope To Erase High Cholesterol For Life”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.